VANI
Vivani Medical, Inc.
-0.00 (-0.37%)1.22USD145K成交股數110M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | 0 | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.5M | 4.4M | 4.6M | 4.5M | 4.8M | 4.2M | 4.2M | 3.5M | 3.7M | 4.7M | 4.4M | 3.9M |
| 銷售管理費用 | 2.4M | 2.4M | 2.2M | 2.2M | 2.7M | 2.3M | 2.1M | 2.2M | 2.5M | 1.5M | 2.7M | 3.1M |
| 營業利益 | −6.9M-8% | −6.8M+4% | −6.8M+8% | −6.7M+18% | −7.5M+20% | −6.6M+5% | −6.3M-12% | −5.7M-19% | −6.2M | −6.2M | −7.1M | −7.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.4M-11% | −6.8M+8% | 46.6M-871% | −6.5M+22% | −7.1M+18% | −6.3M-114% | −6.0M-11% | −5.4M-18% | −6.0M | 45.3M | −6.8M | −6.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.07-42% | -0.08-27% | -0.09-18% | -0.11+10% | -0.120% | -0.11 | -0.11-15% | -0.10-23% | -0.12 | – | -0.13 | -0.13 |
| 稀釋股數 | 87.1M | 81.3M | 62.4M | 59.7M | 59.2M | 59.2M | 55.2M | 55.0M | 52.2M | 50.9K | 50.8M | 50.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.9M | 19.7M | 16.2M | 2.6M | 6.8M | 13.0M | 19.6M | 24.9M | 29.6M | 20.7M | 24.8M | 32.5M |
| 應收帳款 | – | 12K | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 41.6M | 42.4M | 39.4M | 25.0M | 28.9M | 35.5M | 42.9M | 48.2M | 53.8M | 45.8M | 53.3M | 59.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 22.7M | 23.3M | 23.7M | 23.7M | 24.0M | 23.8M | 24.6M | 24.4M | 25.1M | 25.0M | 27.1M | 27.2M |
| 股東權益 | 19.0M | 19.1M | 15.7M | 1.3M | 4.9M | 11.6M | 18.3M | 23.8M | 28.7M | 20.8M | 26.2M | 32.4M |
| 負債比 | 54.4% | 54.9% | 60.1% | 94.8% | 83.0% | 67.2% | 57.3% | 50.6% | 46.6% | 54.7% | 50.8% | 45.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.2M+20% | – | – | – | −5.2M | – | – | −4.5M | – | – | – |
| 資本支出 | – | 3K | – | – | – | 5K | – | – | 182K | – | – | – |
| 自由現金流 | – | −6.2M+20% | – | – | – | −5.2M | – | – | −4.7M | – | – | – |
| 折舊攤銷 | – | 130K | 117K | 105K | 100K | 102K | 107K | 103K | 99K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2018 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2018 年度 · 6.9M
| Argus II Product | 6.9M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | – | 26.6M | –% | -0.43 | −25.5M |
| FY2024 | 0 | – | 23.5M | –% | -0.43 | −21.3M |
| FY2024 | – | – | – | –% | – | – |
| FY2023 | – | – | 25.7M | –% | -0.50 | −24.6M |
| FY2022 | 475K | -13.6% | −13.9M | -2,924.0% | – | −19.1M |
| FY2021 | 550K | +3337.5% | −12.8M | -2,322.4% | -0.27 | −11.5M |
| FY2020 | 16K | -99.5% | −14.9M | -93,000.0% | -0.72 | −17.2M |
| FY2019 | 3.4M | – | −33.6M | -994.1% | -2.28 | −28.1M |